Melanoma Moon Shot update 2014

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/melanoma-moon-shot-update/id43184821... . Cases of melanoma and deaths from this form of skin cancer are on the rise. MD Anderson is ideally suited to tackle this growing challenge because of our unparalleled resources and capabilities. Michael Davies, M.D., Ph.D., associate professor of Melanoma Medical Oncology at MD Anderson Cancer Center, discusses the recent advances made in the organization’s Melanoma Moon Shot program.

Chronic Lymphocytic Leukemia Moon Shot (CLL) update

submitted by: mdanderson

Chronic Lymphocytic Leukemia (CLL) is the most common adult leukemia. Michael Keating, M.D., professor in Leukemia at MD Anderson Cancer Center and one of the leaders in the CLL Moon Shot, discusses new advances in treating CLL, including alternatives to chemotherapy and using one’s own immune system to fight this disease.

Patient registration at MD Anderson Cancer Center

submitted by: mdanderson
Welcome to MD Anderson Cancer Center. In this video, we will explain what to expect during your first visit. Your Patient Access Specialist is one of the first people you will meet. She/he will take you through the registration process, and then you will meet with your care team. We look forward to caring for you and providing exceptional customer service. Call 1-877-632-6789 to make an appointment or visit http://www.mdanderson.org/

Medical and financial clearance at MD Anderson Cancer Center

submitted by: mdanderson
At MD Anderson Cancer Center, we understand that finding out you have cancer is a stressful time. We want to make it easy to set appointments with our experts. To help with this process, a Patient Access Specialist will speak with you to learn more about your medical condition and insurance coverage. In this video, we will explain our financial and medical clearance process, including options for those who don’t have insurance. Thank you for trusting us with your care. We are here for you....

Becoming a patient at MD Anderson Cancer Center

submitted by: mdanderson
Thank you for considering MD Anderson Cancer Center for your cancer care. We see and treat a variety of patients, including the newly diagnosed, those who have received previous cancer treatment, those who simply suspect they have cancer, and those who may be interested in our cancer prevention services. This video will give you an overview of what to expect when becoming a new patient. Together with our patients, our care teams, employees and volunteers are united in one goal of Making...

Best therapies for relapsed diffuse large b-cell lymphoma

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/best-therapies-for-relapsed/id431848... . When diffuse large b-cell lymphoma returns after the cancer patient is initially treated, it is called relapsed diffuse large b-cell lymphoma (DLBCL). If this happens, other therapies besides the standard R-CHOP (chemotherapy drugs cyclophosphamide, doxorubicin, vincristine, and prednisone) may be successful in fighting the disease. Jason Westin, M.D., assistant professor in Lymphoma/Myeloma...